Anhui Provincial Hospital
Clinical trials sponsored by Anhui Provincial Hospital, explained in plain language.
-
New drug combo aims to shield liver during cancer surgery
Disease control Recruiting nowThis study tests whether giving a drug called polyene phosphatidylcholine before and after laparoscopic liver surgery can reduce liver damage in people with liver cancer. About 96 adults will be split into two groups: one gets the drug combo, the other gets standard care. The mai…
Phase: PHASE4 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated May 17, 2026 05:47 UTC
-
Lab-Grown cells offer hope for transplant complication
Disease control Recruiting nowThis study tests a new treatment made from special lab-grown cells (iMSC) for people with a severe complication after bone marrow transplant called graft-versus-host disease that does not respond to steroids. The goal is to see if the treatment is safe and if it can help control …
Phase: NA • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated May 17, 2026 05:36 UTC
-
Gene therapy breakthrough? new trial targets tough lymphoma
Disease control Recruiting nowThis early study tests a new gene therapy (LCAR02) for up to 18 people with B-cell lymphoma that has come back or not responded to treatment. The therapy uses a modified gene to target and attack cancer cells. The main goals are to check safety and see how well the treatment work…
Phase: NA • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Cord blood infusions aim to slow Alzheimer's decline
Disease control Recruiting nowThis study tests whether infusions of cells from umbilical cord blood can help people with mild-to-moderate Alzheimer's disease. Thirty participants will receive either a low dose, high dose, or a placebo (salt water) over five sessions. Researchers will track changes in thinking…
Phase: EARLY_PHASE1 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New combo therapy aims to control advanced esophageal cancer
Disease control Recruiting nowThis study tests a new drug called ivonescimab combined with a short course of radiation for people with advanced esophageal cancer that has worsened after initial treatment. The goal is to see if this combination can help control the cancer and improve survival. The study will e…
Phase: PHASE2 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Supercharged immune cells take on advanced cancers
Disease control Recruiting nowThis early-phase study tests a new treatment called Meta10-TIL for people with advanced solid tumors that have not responded to standard therapy. The treatment involves taking immune cells from the patient's tumor, modifying them to work better, and giving them back. The main goa…
Phase: EARLY_PHASE1 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Timing is everything: new study aims to reduce transplant complications
Disease control Recruiting nowThis study looks at whether changing when stem cells are given during a cord blood transplant can lower the chance of a serious complication called graft-versus-host disease (GVHD). About 134 people with blood cancers who need a transplant will take part. The goal is to find a be…
Phase: PHASE3 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
Kidney transplant study seeks to end guesswork on infection prevention
Disease control Recruiting nowThis study looks at how long kidney transplant patients should take a common antibiotic (TMP-SMX) to prevent a dangerous lung infection called PJP. About 450 participants will be randomly assigned to different treatment lengths. The goal is to find the safest and most effective d…
Phase: NA • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated May 11, 2026 20:46 UTC